EUVIMEDDescoperă EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis

Alexandru Scafa Udriște, Alexandra Cristina Burdușel, Adelina-Gabriela Niculescu iD, Marius Rădulescu, Paul Cătălin Balaure iD, Alexandru Mihai Grumezescu iD

Polymers · 2024-05-16 · 16 (10) · 1421

DOI: 10.3390/polym16101421 ↗

At a glance

Übersichtsarbeit in Polymers, published online on 2024-05-16. Written by Alexandru Scafa Udriște and 5 co-authors. Institution: Department 4 Cardio-Thoracic Pathology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania. Cited 13 times so far (Crossref); 152 references. The full text is freely available (open access, CC BY 4.0). Funded by: EEA.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Cardiovascular diseases (CVDs), the world’s most prominent cause of mortality, continue to be challenging conditions for patients, physicians, and researchers alike. CVDs comprise a wide range of illnesses affecting the heart, blood vessels, and the blood that flows through and between them. Advances in nanomedicine, a discipline focused on improving patient outcomes through revolutionary treatments, imaging agents, and ex vivo diagnostics, have created enthusiasm for overcoming limitations in CVDs’ therapeutic and diagnostic landscapes. Nanomedicine can be involved in clinical purposes for CVD through the augmentation of cardiac or heart-related biomaterials, which can be functionally, mechanically, immunologically, and electrically improved by incorporating nanomaterials; vasculature applications, which involve systemically injected nanotherapeutics and imaging nanodiagnostics, nano-enabled biomaterials, or tissue-nanoengineered solutions; and enhancement of sensitivity and/or specificity of ex vivo diagnostic devices for patient samples. Therefore, this review discusses the latest studies based on applying organic nanoparticles in cardiovascular illness, including drug-conjugated polymers, lipid nanoparticles, and micelles. Following the revised information, it can be concluded that organic nanoparticles may be the most appropriate type of treatment for cardiovascular diseases due to their biocompatibility and capacity to integrate various drugs.

Subjects

Author keywords

cardiovascular diseasesdendrimersliposomesmicellesnanomedicineorganic nanoparticlespolymeric nanoparticles

Authors and institutions

  • Department 4 Cardio-Thoracic Pathology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Department of Science and Engineering of Oxide Materials and Nanomaterials, National University of Science and Technology Politehnica Bucharest, 011061 Bucharest, Romania.
  • Research Institute of the University of Bucharest-ICUB, University of Bucharest, 050657 Bucharest, Romania.
  • Department of Inorganic Chemistry, Physical Chemistry and Electrochemistry, National University of Science and Technology Politehnica Bucharest, 1-7 Polizu St., 011061 Bucharest, Romania.
  • Department of Organic Chemistry, National University of Science and Technology Politehnica Bucharest, 1-7 Polizu St., 011061 Bucharest, Romania.

ORCID profiles: Adelina-Gabriela Niculescu, Paul Cătălin Balaure, Alexandru Mihai Grumezescu

Funding

  • EEA

Cite

APA

Udriște, A. S., Burdușel, A. C., Niculescu, A. G., Rădulescu, M., Balaure, P. C., & Grumezescu, A. M. (2024). Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis. Polymers, 16(10), 1421. https://doi.org/10.3390/polym16101421

Vancouver

Udriște AS, Burdușel AC, Niculescu AG, Rădulescu M, Balaure PC, Grumezescu AM. Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis. Polymers. 2024;16(10):1421. doi:10.3390/polym16101421

BibTeX
@article{Udrite2024,
  author = {Udriște, Alexandru Scafa and Burdușel, Alexandra Cristina and Niculescu, Adelina-Gabriela and Rădulescu, Marius and Balaure, Paul Cătălin and Grumezescu, Alexandru Mihai},
  title = {Organic Nanoparticles in Progressing Cardiovascular Disease Treatment and Diagnosis},
  journal = {Polymers},
  year = {2024},
  volume = {16},
  number = {10},
  pages = {1421},
  doi = {10.3390/polym16101421}
}
Start for free →